IL-12 increases antigen processing and presentation ability by professional antigen-presenting cells, including CD11b+F4/80hi macrophages and CD11b+CD11c+MHCIIhi dendritic cells, and suppresses tumor growth in melanomas [44]. This evidence concerns the gene ITGAX and melanoma.